Prognostic value of clinical and electrophysiological parameters in patients undergoing hybrid therapy for coexisting typical atrial flutter and atrial fibrillation.
Identification of clinical risk factors and biological markers associated with development of atrial low voltage substrate predisposing to atrial fibrillation. Substrate-AF-Study
Speaker:
Doctor Z. Moreno Weidmann (Barcelona, ES)